References
- Abel JJ, Rowntree LG, Turner BB. On the removal of diffusible substances from the circulating blood by dialysis. Trans Assoc Am Physicians 1913; 58:51–54.
- Kyle LH, Jeghers H, Walsh WP, Doolan PD, Wishinsky H, Pallotta A. The application of hemodialysis to the treatment of barbiturate poisoning. J Clin Invest 1953; 32:364–371. Epub 1953/ 04/01.
- Schreiner GE. The role of hemodialysis (artificial kidney) in acute poisoning. AMA Arch Intern Med 1958; 102:896–913.
- Ghannoum M, Nolin TD, Lavergne V, Hoffman RS. Blood purification in toxicology: nephrology's ugly duckling. Adv Chronic Kidney Dis 2011; 18:160–166. Epub 2011/05/03.
- Bailey B, McGuigan M. Comparison of patients hemodialyzed for lithium poisoning and those for whom dialysis was recommended by PCC but not done: what lesson can we learn? Clin Nephrol 2000; 54:388–392. Epub 2000/12/06.
- Atkins D, Best D, Briss PA, Eccles M, Falck-Ytter Y, Flottorp S, . Grading quality of evidence and strength of recommendations. BMJ 2004;328:1490. Epub 2004/06/19.
- Falzon D, Jaramillo E, Schunemann HJ, Arentz M, Bauer M, Bayona J, . WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J 2011; 38:516–528. Epub 2011/08/11.
- Appraisal of Guidelines for Research & Evaluation. AGREE Instrument. London: The AGREE Collaboration; 2001.
- Goldfarb DS. Principles and techniques applied to enhance elimination. In: Nelson LS LN, Howland MA, , editor. Goldfrank's Toxicologic Emergencies, 9th ed. New York, NY: McGraw Hill; 2011: 142.
- Barceloux DG, Bond GR, Krenzelok EP, Cooper H, Vale JA. American academy of clinical toxicology practice guidelines on the treatment of methanol poisoning. J Toxicol Clin Toxicol 2002; 40:415–446. Epub 2002/09/10.
- Barceloux DG, Krenzelok EP, Olson K, Watson W. American academy of clinical toxicology practice guidelines on the treatment of ethylene glycol poisoning. Ad Hoc Committee. J Toxicol Clin Toxicol 1999;3 7:537–560. Epub 1999/09/25.
- Dargan PI, Wallace CI, Jones AL. An evidence based flowchart to guide the management of acute salicylate (aspirin) overdose. Emerg Med J 2002; 19:206–209. Epub 2002/04/25.
- Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schunemann HJ. What is “quality of evidence” and why is it important to clinicians? BMJ 2008; 336:995–998. Epub 2008/05/06.
- Holubek WJ, Hoffman RS, Goldfarb DS, Nelson LS. Use of hemodialysis and hemoperfusion in poisoned patients. Kidney Int 2008; 74:1327–1334. Epub 2008/09/19.
- Holubek WJ. (internal data derived from American Association of Poison Control Centers’ National Poison Data System (NPDS)). 2011.
- Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.
- Murphy MK, Black NA, Lamping DL, McKee CM, Sanderson CF, Askham J, . Consensus development methods, and their use in clinical guideline development. Health technology assessment 1998;2:i–iv, 1–88. Epub 1998/04/30.
- Fitch K, Bernstein SJ, Aguilar MD, Burnand B, LaCalle JR, Lazaro P, . The RAND/UCLA Appropriateness Method User's Manual. Santa Monica, CA2011. Available from: http://www.rand.org/.